Donald Trump signed an executive order to reduce drug prices in the US by 59 to 90 percent by matching the lowest prices in other countries.[1][4][5][6] The measure applies to Medicare and Medicaid programs, private insurers, and includes weight loss drugs.[1] Minister of Health Robert F. Kennedy Jr. it has 30 days to present the goals and start negotiations with the pharmaceutical industry.[1] Trump announced deals with Pfizer to lower drug prices for Medicaid and direct patients via the government's website.[2] Other deals with Eli Lilly and Novo Nordisk are lowering the prices of weight-loss drugs like Zepbound and Wego, which cost about $500 a month at higher doses.[3] Trump launched TrumpRx.gov for cheaper drugs with savings of up to 50 percent.[7][8] Experts expect resistance from drug manufacturers.[1] Drug prices in the US are 2.5 times higher than in France, according to a Rand Corporation study.[2]